martes, 25 de noviembre de 2014

National Guideline Clearinghouse | Hydroxyurea therapy in the management of sickle cell disease. In: Evidence-based management of sickle cell disease.

full-text ►

National Guideline Clearinghouse | Hydroxyurea therapy in the management of sickle cell disease. In: Evidence-based management of sickle cell disease.



National Heart, Lung, and Blood Institute (U.S.)

National Guideline Clearinghouse (NGC)

Guideline Title
Hydroxyurea therapy in the management of sickle cell disease. In: Evidence-based management of sickle cell disease.
Bibliographic Source(s)
Hydroxyurea therapy in the management of sickle cell disease. In: Evidence-based management of sickle cell disease. Bethesda (MD): National Heart, Lung, and Blood Institute (NHLBI); 2014. p. 71-8.
Guideline Status
This is the current release of the guideline.
This guideline meets NGC's 2013 (revised) inclusion criteria.

No hay comentarios:

Publicar un comentario